One Capital Management, LLC Regeneron Pharmaceuticals, Inc. Transaction History

One Capital Management, LLC

$2.94 Billion
Q3 2024

A detailed history of One Capital Management, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, One Capital Management, LLC holds 12,176 shares of REGN stock, worth $8.7 Million. This represents 0.43% of its overall portfolio holdings.

Number of Shares

12,176

Previous 11,668 4.35%

Holding current value

$8.7 Million

Previous $12.3 Million 4.37%

% of portfolio

0.43%

Previous 0.45%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$1024.09 - $1201.76 $520,237 - $610,494	508 Added 4.35%	12,176 $12.8 Million
Q2 2024 Aug 09, 2024	BUY	$883.2 - $1071.19 $594,393 - $720,910	673 Added 6.12%	11,668 $12.3 Million
Q1 2024 May 08, 2024	BUY	$902.69 - $993.35 $22,567 - $24,833	25 Added 0.23%	10,995 $10.6 Million
Q4 2023 Feb 07, 2024	SELL	$775.18 - $881.7 $282,940 - $321,820	-365 Reduced 3.22%	10,970 $9.63 Million
Q3 2023 Nov 09, 2023	BUY	$692.45 - $844.37 $332,376 - $405,297	480 Added 4.42%	11,335 $9.33 Million
Q2 2023 Aug 14, 2023	BUY	$700.03 - $830.35 $202,308 - $239,971	289 Added 2.74%	10,855 $7.8 Million
Q1 2023 May 10, 2023	SELL	$680.49 - $826.97 $38,107 - $46,310	-56 Reduced 0.53%	10,566 $8.68 Million
Q4 2022 Feb 15, 2023	SELL	$705.89 - $766.39 $297,885 - $323,416	-422 Reduced 3.82%	10,622 $7.66 Million
Q3 2022 Nov 14, 2022	BUY	$573.97 - $724.32 $279,523 - $352,743	487 Added 4.61%	11,044 $7.61 Million
Q2 2022 Aug 15, 2022	BUY	$548.35 - $738.84 $20,837 - $28,075	38 Added 0.36%	10,557 $6.24 Million
Q1 2022 May 17, 2022	BUY	$595.12 - $698.43 $85,697 - $100,573	144 Added 1.39%	10,519 $7.35 Million
Q4 2021 Jan 31, 2022	SELL	$543.48 - $670.97 $111,413 - $137,548	-205 Reduced 1.94%	10,375 $6.55 Million
Q3 2021 Nov 12, 2021	SELL	$574.03 - $680.96 $369,101 - $437,857	-643 Reduced 5.73%	10,580 $6.4 Million
Q2 2021 Aug 16, 2021	BUY	$472.8 - $558.54 $429,302 - $507,154	908 Added 8.8%	11,223 $6.27 Million
Q1 2021 May 14, 2021	BUY	$446.73 - $548.2 $558,859 - $685,798	1,251 Added 13.8%	10,315 $4.88 Million
Q4 2020 Feb 16, 2021	BUY	$478.3 - $607.98 $93,746 - $119,164	196 Added 2.21%	9,064 $4.38 Million
Q3 2020 Oct 23, 2020	SELL	$544.75 - $658.21 $96,420 - $116,503	-177 Reduced 1.96%	8,868 $4.96 Million
Q2 2020 Aug 17, 2020	SELL	$493.32 - $643.92 $479,013 - $625,246	-971 Reduced 9.69%	9,045 $5.64 Million
Q1 2020 May 15, 2020	BUY	$336.18 - $494.43 $272,641 - $400,982	811 Added 8.81%	10,016 $4.89 Million
Q4 2019 Jan 31, 2020	BUY	$274.13 - $376.51 $2.52 Million - $3.47 Million	9,205 New	9,205 $3.46 Million

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.6B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of One Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on One Capital Management, LLC with notifications on news.

Account

One Capital Management, LLC Regeneron Pharmaceuticals, Inc. Transaction History